Component 4, which associated with RB outcomes, associated with upregulation of serum IL-12(p40) cytokine measurements, increased expression of genes associated with granulocyte granules and hematopoietic stem cells (HSPCs), and decreased expression of genes associated with dendritic cells and macrophages. This evidence concerns the gene IL9 and retinoblastoma.